Bacteria that are resistant to broad-spectrum antibiotics from the carbapenem group are increasingly posing major problems for healthcare systems worldwide. They can cause serious infections and
Darobactin is a promising candidate for the development of new, resistance-breaking antibiotics, as it has an exceptional mechanism of action and a broad spectrum of activity. In a recent study, DZIF
INCATE, the INCubator for Antibacterial Therapies in Europe, and BIOASTER, the French Technology Research Institute, have announced this week the beginning of a new partnership that aims to improve
The Faculty of Medicine at the University of Basel has awarded an honorary doctorate to DZIF Professor Dr Stephan Urban from the Medical Faculty at the Heidelberg University. The award acknowledges
A team of researchers from Hamburg, Düsseldorf, Erlangen and Cologne has been awarded the German University Medicine Prize for curing the so-called "Düsseldorf patient", who suffered from leukaemia
"We are heading towards a crisis with our eyes wide open. Soon we will lack the antibiotics we need to perform vital operations," says Dr Timo Jäger, Managing Director of the German Center for
From 18 to 24 November, the “World AMR Awareness Week” (WAAW), a global campaign proclaimed by WHO, aims to draw attention to the near-pandemic rise in infections caused by resistant microbial
Professor Gerd Sutter has died at the age of 61. His pioneering work on the development of MVA vaccines against measles, MERS-CoV and West Nile virus, among others, had a major impact on modern
Despite decades of research, there is still no vaccine that protects against HIV infection. It is currently assumed, however, that such a vaccine can only be effective if it also produces so-called
With one of the highest tuberculosis (TB) incidences (368 cases/100,000 population) in the African region, Mozambique is particularly affected by the TB epidemic. Drug-resistant TB is also a major
